Company Information for MOMENTUM BIOSCIENCE LIMITED
UNIT 19 WILLOWBROOK TECHNOLOGY PARK, LLANDOGO ROAD, ST. MELLONS, CARDIFF, WALES, CF3 0EF,
|
Company Registration Number
05594335
Private Limited Company
Active |
Company Name | |
---|---|
MOMENTUM BIOSCIENCE LIMITED | |
Legal Registered Office | |
UNIT 19 WILLOWBROOK TECHNOLOGY PARK LLANDOGO ROAD, ST. MELLONS CARDIFF WALES CF3 0EF Other companies in CF3 | |
Company Number | 05594335 | |
---|---|---|
Company ID Number | 05594335 | |
Date formed | 2005-10-17 | |
Country | ||
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active | |
Lastest accounts | 31/10/2023 | |
Account next due | 31/07/2025 | |
Latest return | 18/09/2015 | |
Return next due | 16/10/2016 | |
Type of accounts | UNAUDITED ABRIDGED | |
VAT Number /Sales tax ID | GB940263835 |
Last Datalog update: | 2024-04-07 01:30:17 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Registered address | Last known status | Formation date | ||
---|---|---|---|---|
Momentum Biosciences, LLC | Delaware | Unknown | ||
MOMENTUM BIOSCIENCES LLC | California | Unknown | ||
MOMENTUM BIOSCIENCES FUND 1 LLC | California | Unknown |
Officer | Role | Date Appointed |
---|---|---|
RAJAT MALHOTRA |
||
WILLIAM PENN MOFFITT |
||
WILLIAM HENRY MULLEN |
||
SAUMIL THAKER |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
JAMES MARK COLLIER |
Director | ||
KEVIN O'DONOVAN |
Director | ||
JOHN CHRISTOPHER LEEKSMA BAILEY |
Company Secretary | ||
DAVID ERIC EVANS |
Director | ||
ROGER JOHN ROSEDALE |
Director | ||
STUART MARK WILSON |
Director |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
CAPTIVE MEDIA LIMITED | Director | 2014-12-16 | CURRENT | 2007-04-17 | Dissolved 2017-12-12 | |
WREN CAPITAL NOMINEES (NO.2) LIMITED | Director | 2012-12-19 | CURRENT | 2011-10-19 | Active | |
WREN CAPITAL NOMINEES LIMITED | Director | 2011-06-02 | CURRENT | 2011-06-02 | Active | |
SARISSA BIOMEDICAL LIMITED | Director | 2017-11-14 | CURRENT | 2002-11-04 | Liquidation | |
BARFORD BIOSCIENCES LIMITED | Director | 2005-10-17 | CURRENT | 2005-10-17 | Dissolved 2015-07-07 |
Date | Document Type | Document Description |
---|---|---|
12/04/24 STATEMENT OF CAPITAL GBP 25963.6 | ||
Director's details changed for Dr William Henry Mullen on 2024-03-28 | ||
Memorandum articles filed | ||
Resolutions passed:<ul><li>Resolution passed removal of pre-emption</ul> | ||
Resolutions passed:<ul><li>Resolution passed removal of pre-emption<li>Resolution passed adopt articles</ul> | ||
CONFIRMATION STATEMENT MADE ON 01/03/24, WITH UPDATES | ||
Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed removal of pre-emption</ul> | ||
Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed removal of pre-emption<li>Resolution passed adopt articles</ul> | ||
Memorandum articles filed | ||
Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed removal of pre-emption</ul> | ||
Resolutions passed:<ul><li>Resolution on securities<li>Resolution passed removal of pre-emption<li>Resolution passed adopt articles</ul> | ||
APPOINTMENT TERMINATED, DIRECTOR WILLIAM PENN MOFFITT | ||
Director's details changed for Dr William Henry Mullen on 2023-07-18 | ||
01/06/23 STATEMENT OF CAPITAL GBP 24623.42 | ||
Register inspection address changed from 24 st Andrews Crescent First Floor Cardiff CF10 3DD Wales to Unit 19 Willowbrook Technology Park Llandogo Road, St. Mellons Cardiff Wales CF3 0EF | ||
CONFIRMATION STATEMENT MADE ON 01/03/23, WITH UPDATES | ||
Resolutions passed:<ul><li>Resolution passed removal of pre-emption</ul> | ||
CS01 | CONFIRMATION STATEMENT MADE ON 01/03/22, WITH UPDATES | |
31/10/21 ACCOUNTS TOTAL EXEMPTION FULL | ||
AA | 31/10/21 ACCOUNTS TOTAL EXEMPTION FULL | |
SH01 | 06/10/21 STATEMENT OF CAPITAL GBP 20531.88 | |
RP04SH01 | Second filing of capital allotment of shares GBP20,531.86 | |
RP04SH01 | Second filing of capital allotment of shares GBP17,934.84 | |
AP01 | DIRECTOR APPOINTED MR JOSE MANENT RELATS | |
SH01 | 06/10/21 STATEMENT OF CAPITAL GBP 17934.84 | |
SH01 | 21/09/21 STATEMENT OF CAPITAL GBP 17934.84 | |
CH01 | Director's details changed for Mr Rajat Malhotra on 2021-06-22 | |
CS01 | CONFIRMATION STATEMENT MADE ON 01/03/21, WITH UPDATES | |
AA | 31/10/20 ACCOUNTS TOTAL EXEMPTION FULL | |
SH01 | 30/03/20 STATEMENT OF CAPITAL GBP 2394.08 | |
CS01 | CONFIRMATION STATEMENT MADE ON 01/03/20, WITH UPDATES | |
RES11 | Resolutions passed:
| |
RES11 | Resolutions passed:
| |
AA | 31/10/19 ACCOUNTS TOTAL EXEMPTION FULL | |
AP01 | DIRECTOR APPOINTED MR MATTHEW GERARD WINSTON FROHN | |
SH01 | 31/07/19 STATEMENT OF CAPITAL GBP 1461.84 | |
SH01 | 17/06/19 STATEMENT OF CAPITAL GBP 1440.06 | |
RES10 | Resolutions passed:
| |
SH01 | 05/04/19 STATEMENT OF CAPITAL GBP 1327.06 | |
RES11 | Resolutions passed:
| |
CS01 | CONFIRMATION STATEMENT MADE ON 01/03/19, WITH UPDATES | |
AA | 31/10/18 ACCOUNTS TOTAL EXEMPTION FULL | |
LATEST SOC | 10/05/18 STATEMENT OF CAPITAL;GBP 855.16 | |
SH01 | 30/03/18 STATEMENT OF CAPITAL GBP 855.16 | |
CS01 | CONFIRMATION STATEMENT MADE ON 01/03/18, WITH UPDATES | |
LATEST SOC | 27/02/18 STATEMENT OF CAPITAL;GBP 848.9 | |
SH01 | 15/02/18 STATEMENT OF CAPITAL GBP 848.9 | |
RES11 | Resolutions passed:
| |
RES11 | Resolutions passed:
| |
LATEST SOC | 07/02/18 STATEMENT OF CAPITAL;GBP 792.62 | |
SH01 | 26/01/18 STATEMENT OF CAPITAL GBP 792.62 | |
AA | 31/10/17 ACCOUNTS TOTAL EXEMPTION FULL | |
RES11 | Resolutions passed:
| |
LATEST SOC | 21/12/17 STATEMENT OF CAPITAL;GBP 703.68 | |
SH01 | 20/12/17 STATEMENT OF CAPITAL GBP 703.68 | |
LATEST SOC | 25/10/17 STATEMENT OF CAPITAL;GBP 667.16 | |
SH01 | 30/09/17 STATEMENT OF CAPITAL GBP 667.16 | |
LATEST SOC | 19/10/17 STATEMENT OF CAPITAL;GBP 665.9 | |
RP04SH01 | SECOND FILED SH01 - 02/08/17 STATEMENT OF CAPITAL GBP 665.90 | |
RP04SH01 | SECOND FILED SH01 - 02/08/17 STATEMENT OF CAPITAL GBP 640.90 | |
ANNOTATION | Clarification | |
RP04SH01 | SECOND FILED SH01 - 02/08/17 STATEMENT OF CAPITAL GBP 665.90 | |
RP04SH01 | SECOND FILED SH01 - 02/08/17 STATEMENT OF CAPITAL GBP 640.90 | |
RES11 | Resolutions passed:
| |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
RP04SH01 | Second filing of capital allotment of shares GBP639.64 | |
LATEST SOC | 18/08/17 STATEMENT OF CAPITAL;GBP 498.68 | |
SH01 | 02/08/17 STATEMENT OF CAPITAL GBP 498.68 | |
SH01 | 02/08/17 STATEMENT OF CAPITAL GBP 498.68 | |
SH01 | 02/08/17 STATEMENT OF CAPITAL GBP 473.68 | |
SH01 | 02/08/17 STATEMENT OF CAPITAL GBP 473.68 | |
SH01 | 19/06/17 STATEMENT OF CAPITAL GBP 473.68 | |
SH01 | 21/04/17 STATEMENT OF CAPITAL GBP 323.68 | |
RES11 | Resolutions passed:
| |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
RES11 | DISAPPLICATION OF PRE-EMPTION RIGHTS | |
RES10 | Resolutions passed:
| |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MR SAUMIL THAKER / 15/03/2017 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / DR WILLIAM HENRY MULLEN / 15/03/2017 | |
SH01 | 03/04/16 STATEMENT OF CAPITAL GBP 299.58 | |
CS01 | CONFIRMATION STATEMENT MADE ON 01/03/17, WITH UPDATES | |
RES11 | DISAPPLICATION OF PRE-EMPTION RIGHTS | |
AA | 31/10/16 TOTAL EXEMPTION SMALL | |
AP01 | DIRECTOR APPOINTED MR SAUMIL THAKER | |
AD02 | SAIL ADDRESS CREATED | |
LATEST SOC | 30/09/16 STATEMENT OF CAPITAL;GBP 298.22 | |
CS01 | CONFIRMATION STATEMENT MADE ON 18/09/16, WITH UPDATES | |
MR04 | STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 055943350001 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR JAMES COLLIER | |
AP01 | DIRECTOR APPOINTED MR WILLIAM MOFFITT | |
AA | 31/10/15 TOTAL EXEMPTION SMALL | |
LATEST SOC | 28/09/15 STATEMENT OF CAPITAL;GBP 298.22 | |
AR01 | 18/09/15 FULL LIST | |
SH01 | 17/07/15 STATEMENT OF CAPITAL GBP 277.70 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / RAHAT MALHOTRA / 17/08/2015 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / JAMES MARK COLLIER / 17/08/2015 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR KEVIN O'DONOVAN | |
LATEST SOC | 27/04/15 STATEMENT OF CAPITAL;GBP 239.52 | |
SH01 | 02/04/15 STATEMENT OF CAPITAL GBP 239.52 | |
RES12 | VARYING SHARE RIGHTS AND NAMES | |
RES01 | ADOPT ARTICLES 01/04/2015 | |
AA | 31/10/14 TOTAL EXEMPTION SMALL | |
LATEST SOC | 13/10/14 STATEMENT OF CAPITAL;GBP 128.06 | |
AR01 | 18/09/14 FULL LIST | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / DR WILLIAM HENRY MULLEN / 01/10/2009 | |
AP01 | DIRECTOR APPOINTED MR KEVIN O'DONOVAN | |
TM02 | APPOINTMENT TERMINATED, SECRETARY JOHN BAILEY | |
AD01 | REGISTERED OFFICE CHANGED ON 07/08/2014 FROM UNIT 18 WILLOWBROOK TECHNOLOGY PARK LLANDOGO ROAD ST. MELLONS CARDIFF CF3 0EF WALES | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR DAVID EVANS | |
RES13 | INCREASE IN SHARE CAP 11/03/2014 | |
RES01 | ADOPT ARTICLES 11/03/2014 | |
SH01 | 14/03/14 STATEMENT OF CAPITAL GBP 128.06 | |
SH10 | NOTICE OF PARTICULARS OF VARIATION OF RIGHTS ATTACHED TO SHARES | |
MR01 | REGISTRATION OF A CHARGE / CHARGE CODE 055943350001 | |
AD01 | REGISTERED OFFICE CHANGED ON 07/02/2014 FROM UNIT 18 WILLOWBROOK TECHNOLOGY PARK CRICKHOWELL ROAD ST. MELLONS CARDIFF CF3 0EX WALES | |
AD01 | REGISTERED OFFICE CHANGED ON 06/02/2014 FROM 2 PARKHILL DRIVE READING BERKSHIRE RG31 6LB | |
AA | 31/10/13 TOTAL EXEMPTION SMALL | |
AA01 | PREVSHO FROM 31/12/2013 TO 31/10/2013 | |
AR01 | 18/09/13 FULL LIST | |
AA | 31/12/12 TOTAL EXEMPTION SMALL | |
AR01 | 17/10/12 FULL LIST | |
AD01 | REGISTERED OFFICE CHANGED ON 13/11/2012 FROM BEVANS 46 ESSEX STREET LONDON WC2R 3JF | |
AA | 31/12/11 TOTAL EXEMPTION SMALL | |
RES01 | ADOPT ARTICLES 14/03/2012 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
AR01 | 17/10/11 FULL LIST | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ROGER ROSEDALE | |
AP01 | DIRECTOR APPOINTED RAHAT MALHOTRA | |
SH01 | 02/09/11 STATEMENT OF CAPITAL GBP 79.06 | |
SH01 | 02/09/11 STATEMENT OF CAPITAL GBP 7298 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
RES04 | NC INC ALREADY ADJUSTED 17/08/2011 | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
AA | 31/12/10 TOTAL EXEMPTION SMALL | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR STUART WILSON | |
AR01 | 17/10/10 FULL LIST | |
AA | 31/12/09 TOTAL EXEMPTION FULL | |
AP01 | DIRECTOR APPOINTED JAMES MARK COLLIER | |
SH01 | 21/07/10 STATEMENT OF CAPITAL GBP 51.76 | |
SH01 | 21/07/10 STATEMENT OF CAPITAL GBP 51.74 | |
SH01 | 30/04/10 STATEMENT OF CAPITAL GBP 42.28 | |
SH01 | 12/03/10 STATEMENT OF CAPITAL GBP 0.02 | |
AP01 | DIRECTOR APPOINTED DAVID ERIC EVANS | |
AD01 | REGISTERED OFFICE CHANGED ON 05/02/2010 FROM MTA CORPORATE SOLICITORS LLP 5 BREAM'S BUILDINGS LONDON EC4Y 1DX | |
AR01 | 17/10/09 FULL LIST | |
SH01 | 16/06/09 STATEMENT OF CAPITAL GBP 36.62 | |
AA | 31/12/08 TOTAL EXEMPTION FULL | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / WILLIAM HENRY MULLEN / 03/10/2009 | |
288a | DIRECTOR APPOINTED DR STUART MARK WILSON | |
88(2) | AD 16/06/09 GBP SI 289@0.02=5.78 GBP IC 32.04/37.82 | |
88(2) | AD 16/03/09 GBP SI 60@0.02=1.2 GBP IC 30.84/32.04 | |
288a | DIRECTOR APPOINTED ROGER JOHN ROSEDALE | |
287 | REGISTERED OFFICE CHANGED ON 04/12/2008 FROM 19 LOVATT CLOSE READING RG31 5HG | |
363a | RETURN MADE UP TO 17/10/08; FULL LIST OF MEMBERS | |
AA | 31/12/07 TOTAL EXEMPTION FULL | |
88(2) | AD 14/07/08 GBP SI 20@0.02=0.4 GBP IC 31.42/31.82 | |
88(2) | AD 14/07/08 GBP SI 60@0.02=1.2 GBP IC 30.22/31.42 | |
RES01 | ADOPT ARTICLES 08/04/2008 | |
363a | RETURN MADE UP TO 17/10/07; FULL LIST OF MEMBERS | |
AA | TOTAL EXEMPTION FULL ACCOUNTS MADE UP TO 31/10/06 | |
225 | ACC. REF. DATE EXTENDED FROM 31/10/07 TO 31/12/07 | |
363s | RETURN MADE UP TO 17/10/06; FULL LIST OF MEMBERS | |
NEWINC | INCORPORATION DOCUMENTS CERTIFICATE OF INCORPORATION STATEMENT OF DIRECTORS & REGISTERED OFFICE DECLARATION OF COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
Total # Mortgages/Charges | 1 |
---|---|
Mortgages/Charges outstanding | 0 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 1 |
Charge Type | Date of Charge | Charge Status | Mortgagee |
---|---|---|---|
Satisfied | LONWALL VENTURE PARTNERS LLP AS SECURITY TRUSTEE |
Creditors Due After One Year | 2013-10-31 | £ 380,760 |
---|---|---|
Creditors Due After One Year | 2013-01-01 | £ 380,760 |
Creditors Due Within One Year | 2013-10-31 | £ 93,723 |
Creditors Due Within One Year | 2013-01-01 | £ 57,356 |
Creditors and other liabilities
These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on MOMENTUM BIOSCIENCE LIMITED
Called Up Share Capital | 2013-01-01 | £ 79 |
---|---|---|
Cash Bank In Hand | 2013-10-31 | £ 4,530 |
Cash Bank In Hand | 2013-01-01 | £ 158,029 |
Current Assets | 2013-10-31 | £ 63,399 |
Current Assets | 2013-01-01 | £ 201,009 |
Debtors | 2013-10-31 | £ 58,869 |
Debtors | 2013-01-01 | £ 42,980 |
Tangible Fixed Assets | 2013-10-31 | £ 47,682 |
Tangible Fixed Assets | 2013-01-01 | £ 63,398 |
Debtors and other cash assets
The top companies supplying to UK government with the same SIC code (32500 - Manufacture of medical and dental instruments and supplies) as MOMENTUM BIOSCIENCE LIMITED are:
CENTRAL LONDON COMMUNITY HEALTHCARE LIMITED | £ 10,847,999 |
BUPA CARE HOMES (PARTNERSHIPS) LIMITED | £ 127,680 |
ALPHA CARE AMBULANCE SERVICE LIMITED | £ 52,560 |
NESTOR PRIMECARE SERVICES LIMITED | £ 34,345 |
SOUTH COAST NURSING HOMES LIMITED | £ 18,979 |
ST MARTINS HEALTHCARE (SERVICES) CIC | £ 13,079 |
QUALITY CARE MANAGEMENT LIMITED | £ 9,232 |
CENTRAL LONDON HEALTHCARE CIC | £ 7,657 |
SOUTHBOURNE SURGERY LIMITED | £ 6,825 |
COMPASS PSYCARE LTD | £ 5,107 |
TURNING POINT (SERVICES) LIMITED | £ 105,144,516 |
CENTRAL LONDON COMMUNITY HEALTHCARE LIMITED | £ 13,804,089 |
NESTOR PRIMECARE SERVICES LIMITED | £ 6,918,443 |
AVENS LTD | £ 5,005,475 |
THREE SISTERS LTD | £ 2,594,483 |
QUALITY CARE MANAGEMENT LIMITED | £ 2,535,456 |
ABL HEALTH LIMITED | £ 2,286,212 |
HCRG CARE PROVIDER SERVICES LTD | £ 1,656,025 |
HCRG CARE SERVICES LTD | £ 1,609,843 |
PSYCHOLOGY ASSOCIATES LIMITED | £ 1,384,546 |
TURNING POINT (SERVICES) LIMITED | £ 105,144,516 |
CENTRAL LONDON COMMUNITY HEALTHCARE LIMITED | £ 13,804,089 |
NESTOR PRIMECARE SERVICES LIMITED | £ 6,918,443 |
AVENS LTD | £ 5,005,475 |
THREE SISTERS LTD | £ 2,594,483 |
QUALITY CARE MANAGEMENT LIMITED | £ 2,535,456 |
ABL HEALTH LIMITED | £ 2,286,212 |
HCRG CARE PROVIDER SERVICES LTD | £ 1,656,025 |
HCRG CARE SERVICES LTD | £ 1,609,843 |
PSYCHOLOGY ASSOCIATES LIMITED | £ 1,384,546 |
TURNING POINT (SERVICES) LIMITED | £ 105,144,516 |
CENTRAL LONDON COMMUNITY HEALTHCARE LIMITED | £ 13,804,089 |
NESTOR PRIMECARE SERVICES LIMITED | £ 6,918,443 |
AVENS LTD | £ 5,005,475 |
THREE SISTERS LTD | £ 2,594,483 |
QUALITY CARE MANAGEMENT LIMITED | £ 2,535,456 |
ABL HEALTH LIMITED | £ 2,286,212 |
HCRG CARE PROVIDER SERVICES LTD | £ 1,656,025 |
HCRG CARE SERVICES LTD | £ 1,609,843 |
PSYCHOLOGY ASSOCIATES LIMITED | £ 1,384,546 |
Origin | Destination | Date | Import Code | Imported Goods classification description |
---|---|---|---|---|
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
29349990 | Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
90273000 | Spectrometers, spectrophotometers and spectrographs using optical radiations, such as UV, visible, IR | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
29343090 | Heterocyclic compounds containing in the structure a phenothiazine ring-system, whether or not hydrogenated, but not further fused (excl. thiethylperazine "INN", and thioridazine "INN" and its salts) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) |
For goods imported into the United Kingdom, only imports originating from outside the EU are shown
Category | Award/Grant | |
---|---|---|
Automating a platform for rapid clinical microbiology : Smart - Proof of Concept | 2013-04-01 | £ 85,206 |
Improving patient outcomes using rapid, effective antibiotic susceptibility testing : Small Business Research Initiative | 2012-09-01 | £ 88,835 |
How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |